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Influence of Acute Arterial Hypertension on Myocardial Infarct Size in
Dogs Without Left Ventricular Hypertrophy
ROBERTO BOLLI, MD, LAWRENCE C. KUO, MD, ROBERT ROBERTS, MD, FACC
Houston, Texas
During acute myocardial infarction an increase in ar-
terial pressure is common in patients who were previ-
ously normotensive and, therefore, do not have left ven-
tricular hypertrophy. However, the effect of hyperten-
sion on infarct size in the absence of hypertrophy is
uncertain. Thus, 32 open chest dogs underwent a 2 hour
occlusion of the mid-left anterior descending coronary
artery followed by 3 hours of reperfusion. Immediately
after occlusion, 14 dogs were randomized to a hyper-
tension group (intravenous phenylephrine infusion
starting 5 minutes after occlusionand terminating at the
time of reperfusion, with heart rate kept constant by
atrial pacing) and 18 dogs to a control group (equivalent
volumes of saline solution intravenously). Twelveof the
32 dogs were excluded from analysis because they de-
veloped ventricular fibrillation during coronary occlu-
sion or reperfusion.
In the hypertension group (n=10), the mean arterial
pressure increased significantlywithin 10minutes of cor-
onary occlusion (146 ± 7 versus 109 ± 11 mm Hg in
10 control dogs, p < 0.01) and was maintained approx-
Although systemic arterial hypertension is common in acute
myocardial infarction (l,2), its influence on ischemic
damage is not well understood. Shell and Sobel (3) reported
that a reduction in blood pressure by trimethaphan decreases
infarct size in hypertensive patients with acute myocardial
infarction. However, because trimethaphan also reduces
cardiac sympathetic stimulation, the exact mechanism for
the limitation of infarct size in that study remains unclear.
Global left ventricular function may improve when afterload
is reduced in patients with acute myocardial infarction (4,5),
but this effect does not necessarily imply limitation of isch-
emic damage (5). Studies in experimental animals have not
fully clarified this problem. Dogs with chronic arterial hy-
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imately 40 mm Hg higher than in the control group (p
< 0.01) throughout the ischemic period. Heart rate was
similar in the two groups throughout the experiment.
After the dogs were sacrificed, the region normally sup-
plied by the occluded artery (anatomic "region at risk")
was identified by simultaneous perfusion of the aortic
root and the coronary artery distal to the occlusion. The
heart was sectioned transversely and stained with tri-
phenyltetrazolium-chloride. The infarcted area and the
anatomic risk area were determined by video planim-
etry. Control and hypertension groups did not differ
significantly in the percent of left ventricle infarcted (14
± 2 [mean ± standard error] and 13 ± 3%, respec-
tively)or in the percent of anatomic risk region infarcted
(41 ± 5 and 37 ± 7%, respectively).
It is concluded that acute arterial hypertension un-
associated with left ventricular hypertrophy has neither
detrimental nor beneficial effects on the size of myocar-
dial infarction resulting from a temporary coronary oc-
clusion followed by reperfusion.
pertension and left ventricular hypertrophy exhibit larger
infarcts and higher mortality than do normotensive control
dogs (6,7). These results, however, may reflect the en-
hanced vulnerability of hypertrophic myocardium to isch-
emia (8) rather than an effect of hypertension as such. In
dogs without left ventricular hypertrophy, elevation of ar-
terial pressure favorably affects electrocardiographic (9,10)
and metabolic (11,12) indexes of ischemia during brief cor-
onary occlusion, but the impact on infarct size after sus-
tained ischemia has not been ascertained.
The influence of hypertension per se on infarct size is of
significant clinical interest as many patients with acute myo-
cardial infarction and hypertension do not have left ven-
tricular hypertrophy. Approximately one-third of normo-
tensive subjects may become hypertensive in the early phase
of myocardial infarction as a result of pain, fear and agitation
(I ,2), release of norepinephrine from damaged myocardium
(13) or stimulation of chemoreceptors supplied by the coro-
nary arteries (14). Furthermore, if a hypertensive disorder
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preceding the infarction was labile, mild or of recent onset,
cardiac mass will likely be normal. The appropriate man-
agement of these patients with hypertension but without
hypertrophy remains largely uncertain for it is unknown
whether the influence of the hypertensive state on infarct
size is heneficial (because of increased collateral perfusion
[12, IS,16]) , deleterious (because of enhanced oxygen de-
mands) or neither.
In an effort to clarify these problems experimentally, we
assessed the effect of elevated arterial pressure on anatom-
ically estimated infarct size in open chest dogs without left
ventricular hypertrophy. The study was designed to mini-
mize the interference of such variables as heart rate and size
of region at risk. Hypertension was maintained throughout
the duration of myocardial ischemia to maximize the like-
lihood of detecting any effect on infarct size. The elevation
of arterial pressure was limited to approximately 40 mm Hg
because higher degrees of hypertension are rarely observed
in patients 0 ,2) .
Methods
Experimental preparation. Thirty-two mongrel dogs
of either sex, weighing 14 to 28 kg, were sedated with
sodium thiamylal 00 mg/kg intravenously) and anesthetized
10 minutes later with alpha-chloralose (70 mg/kg intrave-
nously) . Additional doses of alpha-chloralose were admin-
istered during the experiment to abolish the corneal reflex.
The dogs were intubated and ventilated with room air. The
chest was opened through the left fifth intercostal space and
the heart was suspended in a pericardial cradle. The left
anterior descending coronary artery was isolated from the
surrounding tissues and encircled by a snare. The site of
occlusion was chosen to produce ischemic zones of uniform
size approximating two-thirds of the anterior surface of the
left ventricle, as described previously (7). Polyethylene
catheters were inserted through the left atrial appendage into
the left atrium and through the left carotid artery into the
aorta . Both catheters were connected to a Statham P23Db
pressure transducer. A solid state pressure transducer (Kon-
igsberg, model P-20) was positioned in the left ventricular
cavity through an incision in the ventricular apex. The first
derivative of left ventricular pressure (dP/dt) was obtained
by electronic differentiation. Aortic pressure, left ventricular
pressure , dP/dt, left atrial pressure and lead II of the elec-
trocardiogram were recorded continuously throughout the
study on an eight channel , direct writing oscillograph (Gould
Brush, system 200).
Experimental protocol. After baseline data were re-
corded , the left anterior descending coronary artery was
occluded with a bulldog clamp. Immediately after occlu-
sion, dogs were randomized to a hypertension (n = 14) or
control (n = 18) group. Animals in the hypertension group
received a continuous intravenous infusion of phenyleph-
rine, beginning 5 minutes after occlusion and continuing
until reperfusion . The infusion rate was adjusted to increase
mean aortic pressure by approximately 40 mm Hg and av-
eraged 88 ± 21 ug /kg per min (mean volume of infusion
72 ± 8 mllh) . Because the elevation of arterial pressure by
phenylephrine was associated with a reflex decrease of heart
rate , the left atrium was paced throughout the occlusion
phase at a rate equal to the pretreatment sinus rate. This
permitted assessment of the influence of hypertension on
infarct size without the interference of changes in heart rate .
Control dogs received equivalent volumes of normal saline
solution intravenously. No attempt was made to resuscitate
animals that developed ventricular fibrillation.
Two hours after occlusion, the left anterior descending
coronary artery was reperfused by removing the clamp. In
the hypertension group, phenylephrine infusion and left
atrial pacing were discontinued immediately after occlusion
release .
Identification and measurement of the anatomic re-
gion at risk of infarction. Three hours after coronary re-
perfusion, dogs were sacrificed by intravenous injection of
cadmium chloride. The heart was excised and placed in ice-
cold saline solution . The anatomic region at risk of infarction
(that is, the portion of the left ventricle normally supplied
by the occluded artery) was identified by a previously de-
scribed technique (8) . In summary, one cannula was in-
serted into the left anterior descending coronary artery just
below the site of occlusion and a second cannula was in-
serted into the aortic root. The arterial bed distal to the
occlusion was then perfused with 1% brilliant blue dye in
normal saline solution while the aortic root was simulta-
neously perfused with saline solution. Equal physiologic
pressures were applied to the aortic and distal left anterior
descending coronary artery cannulas to prevent flow across
collateral vessels. As a result of this procedure, the myo-
cardium normally perfused by the occluded portion of the
coronary artery (anatomic region at risk) was stained blue,
while the rest of the heart remained unstained. The risk
region, as defined in this study, is an anatomic designation
of the collateral -dependent portion of the heart. Our tech-
nique does not specify the competence of collateral vessels
or the metabolic demands of the myocardium, factors that
determine the actual amount of necrosis within the risk
region.
The heart was sectioned from apex to base into I em
thick slices in a plane parallel to the atrioventricular groove,
and the border between stained and unstained tissue, which
was assumed to be the limit of the region at risk , was marked
by a small incision on each cut surface .
Estimation ofinfarct size. To identify the infarct within
the anatomic region at risk, slices were weighed and in-
cubated for 45 minutes in 1% triphenyltetrazolium-chloride
solution at 38°C. This agent stains only viable dehydro-
genase-containing myocardium dark red (19). Triphenyl-
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tetrazolium-chloride has been shown to accurately identify
irreversibly injured myocytes as early as 3 hours after cor-
onary artery occlusion (20). When coronary occlusion is
followed by reperfusion, clear delineation of necrotic areas
by this agent has been observed after even shorter ischemic
periods (30 to 35 minutes) (20), possibly because of
"washout" of enzymes. The weights of the anatomic region
at risk and of the infarct were determined by tracing the
portion at risk and the necrotic portion of each slice on
transparent plastic sheets. Each area was measured by video
planimetry and the masses of the risk region and the infarct
expressed as fractions of the weight of each slice (18). Total
infarct mass was expressed as percent both of the left ven-
tricle and of the myocardium at risk.
Statistical analysis. Values are reported as mean ±
standard error of the mean. Regression lines were fitted to
the grouped data using the least squares method. The x axis
intercepts and their standard errors were calculated by reen-
tering the data with x and y axes reversed. The two-tailed
Student's t test for unpaired data was used to compare means
as well as intercepts and slopes of the regression lines of
the r~lations between infarct size and risk region. The chi-
square test with Yates' correction for continuity was used
to analyze the differences in mortality rate.
Results
Incidence of ventricular fibrillation. Arterial hyper-
tension did not significantly affect the incidence of sudden
arrhythmic death associated with myocardial ischemia or
reperfusion. During the coronary artery occlusion phase,
ventricular fibrillation occurred in 5 (28%) ofthe 18 control
dogs and in 3 (21%) of the 14 dogs with hypertension.
During the coronary reperfusion phase, 3 (23%) of the 13
control dogs and 1 (9%) of the II hypertensive dogs de-
veloped the arrhythmia. As a result, 20 dogs completed the
protocol (10 in each group) and were included in the analysis
of results.
Hemodynamics. Heart rate, aortic pressure and mean
left atrial pressure were similar in the two groups before
coronary artery occlusion as well as 5 minutes after occlu-
sion (that is, immediately before treatment) (Fig. 1 and 2).
Systolic and diastolic aortic pressures increased rapidly in
treated dogs as phenylephrine infusion was begun, and by
10 minutes of occlusion reached levels significantly (p <
0.01) higher than those in the control group (Fig. I). Mean
aortic pressure remained approximately 40 mm Hg greater
in the hypertension group throughout the period of ischemia
(p < 0.01 at each time point). After coronary reperfusion,
phenylephrine infusion was discontinued and aortic pressure
in treated dogs returned to levels comparable with those
observed in control dogs. Pacing was performed in hyper-
tensive dogs to prevent the decrease in heart rate associated
with the elevation of arterial pressure. As a result, heart rate
was similar in the two groups throughout the experimental
protocol (Fig. 2). Although left atrial pressure increased
during phenylephrine infusion (p < 0.05 versus pretreat-
ment values), it did not differ statistically from that of con-
trol dogs (Fig. 2). Thus, the only significant hemodynamic
difference between the two groups was an increase in arterial
pressure in treated dogs that began 5 minutes after coronary
occlusion and persisted until reperfusion.
Infarct size. The mass of the left ventricle and that of
the occluded coronary bed (anatomic region at risk) were
similar in control and hypertensive dogs (Fig. 3). The two
groups did not differ significantly in the size of the infarct
expressed in grams, as a percent of the left ventricle or as
a percent of the anatomic risk region. Even when the risk
regions were arbitrarily divided into "small" and "large"
(::::; and >32% of the left ventricle, respectively), the percent
of risk region infarcted was similar in control and hyper-
tensive dogs: 30 ± 7 (n =5) versus 27 ± 6% (n =6),
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Figure 1. Systolic (squares), diastolic (triangles)
and mean (circles) aortic pressure in control and
hypertension groups. Vertical bars represent 1
standard errorofthe mean. *p < 0.01, **p< 0.001
versus control group at the corresponding time
point.
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Figure 2. Heart rate (upper panel) and
mean left atrial pressure (LAP) (lower
panel) in control and hypertension groups.
Vertical bars indicate I standard error of
the mean.
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respectively, for small risk regions, and 51 ± 3 (n = 5)
versus 53 ± 9% (n = 4), respectively, for large risk regions.
The mass of the infarct was directly and closely related
to the mass of the anatomic region at risk in both the control
(r = 0.91, P < 0.001) and the hypertension group (r =
0.82, p < 0.001) (Fig. 4). Neither the slope ofthe regression
line nor the intercept for zero infarct was significantly dif-
ferent in the two groups. Thus, arterial hypertension failed
to alter the relation between the magnitude of necrosis and
the size of the occluded coronary bed over the entire range
Figure 3. Left panel, Weight of left ventricle (LV), anatomic
region at risk (RR) and infarct (I) in control and hypertension
groups. Right panel, Weight ofregion at risk as percent of weight
of left ventricle (RRILV) (left), weight of infarct as percent of
weight of left ventricle (IlLV) (middle) and weight of infarct as
percent of region at risk (IIRR) (right). Vertical bars indicate I
standard error of the mean. No significant difference was observed
between the two groups.
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of occluded beds that we examined (17 to 43% of the left
ventricle).
Discussion
This study demonstrates that in the absence of left ven-
tricular hypertrophy, acute elevation of arterial pressure,
albeit marked and maintained throughout the period of isch-
emia, does not significantly affect the extent of myocardial
necrosis resulting from a temporary coronary artery occlu-
sion followed by reperfusion.
Modeling considerations. In our study, arterial pres-
sure was elevated by administering the alpha-adrenergic
agonist phenylephrine. Compared with other experimental
techniques, this mechanism of hypertension more closely
resembles the increased alpha-adrenergic activity that is
thought to cause the acute increases in blood pressure during
the early phase of myocardial infarction in human beings
(1,2,13,14). However, the possibility that different results
might be obtained with other types of acute hypertension
(for example, aortic constriction) cannot be excluded.
A temporary coronary occlusion was preferred to a per-
manent obstruction for several reasons. First, it appeared
more suitable for detecting infarct extension. The 2 hour
ischemic period followed by reperfusion resulted in a sub-
endocardial infarction limited to approximately 40% of the
anatomic risk region, whereas a permanent coronary occlu-
sion in open chest dogs produces transmural necrosis ex-
tending to approximately 80% of the risk region (18).
Clearly, if hypertension increases infarct size, such an effect
526 BOLLI ET AL.
HYPERTENSION AND INFARCT SIZE
lACC Vol. 4. No.3
September 1984:522-8
40
• CONTROL r =0.91 (P< .001)
y =1.06x - 20.0
5> 30 o HTN r =0.82 (P< .001)
..J Y=1.22x - 26.0
'0
~ 20
I-
U
a:
<t
LL
~
10
o
Figure 4. Relation between the masses of infarct and risk region
normalized by the mass of left ventricle (LV) in the control and
in thehypertension (HTN) groups. There wasa closedirect relation
in both groups. No significant difference was observed between
control and hypertensive dogs in the slope of the regression line
(1.06 ± 0.16 versus 1.22 ± 0.10, respectively) or in theintercept
of x axis ([region at risk for which infarct does not occur] 19 ±
2 versus 21 ± 2, respectively).
may not be manifest when most of the jeopardized myo-
cardium is already fated to die. Second, by using a tem-
porary occlusion it was possible to maintain elevated arterial
pressures under carefully controlled conditions throughout
the period of ischemia, when myocellular damage is pro-
duced. This enabled us to rule out the possibility that an
early beneficial effect of hypertension was missed at the end
of the experiment because of insufficient duration of treat-
ment. The maintenance of a steady hypertensive state for
the entire duration of the ischemic period may be more
difficult when a permanent occlusion is used. Third, our
model of coronary occlusion followed by reperfusion sim-
ulates a frequent clinical event. It is now clear that spon-
taneous recanalization of the infarct-related artery occurs in
a significant proportion of cases after the first few hours of
acute myocardial infarction due to lysis of thrombus, re-
versal of spasm, or both (21,22). Moreover, early coronary
reperfusion by intracoronary (23) or intravenous (24) strep-
tokinase is becoming an increasingly common approach to
acute myocardial infarction.
Effect of hypertension on the relation between infarct
size and occluded bed (anatomic region at risk). The
importance of our data indicating failure of hypertension to
alter the relation between extent of necrosis and size of
occluded bed needs to be emphasized. The close relation
between mass of infarct and mass of anatomic region at risk
in control dogs implies that part of the variability of infarct
size is due to variation in the size of the occluded coronary
bed. Normalizing mass of infarct to mass of anatomic risk
region minimizes this variability and enhances the ability
of the technique to detect differences (18,25,26). Further-
more, expressing infarct mass as a percent of myocardium
at risk affords determination of whether the effect of a given
intervention on infarct size varies with the size of the oc-
cluded coronary bed. This analysis is necessary in light of
recent data (27) indicating that infarct-sparing interventions
are more effective when the region at risk is small. In our
study, no effect of hypertension on the percent of necrosis
within the anatomic region at risk was detected, even when
the analysis was limited to the smaller risk regions.
Previous studies of hypertension and infarct size. The
impact of arterial hypertension on infarct size is difficult to
predict because hypertension may increase both oxygen de-
mands and perfusion (12,15,16) of ischemic myocardium.
Relatively few studies have addressed this problem. Koy-
anagi et al. (6,7) demonstrated that chronic hypertension
associated with left ventricular hypertrophy increases infarct
size (6) and mortality (7) after permanent coronary occlusion
in conscious dogs. However, the relative contributions of
hypertension and hypertrophy to these deleterious effects
remain to be determined. Conceivably, left ventricular hy-
pertrophy may exacerbate ischemic injury because of the
fundamental abnormalities of the coronary circulation in-
herent in this condition (increased diffusion distance from
capillaries to center of myocytes [28,29], reduced coronary
vascular reserve [8]). Furthermore, the tendency for col-
lateral flow to be lower in hypertensive dogs despite higher
coronary perfusion pressures (6) suggests that collateral de-
velopment may also be impaired in the hypertrophic heart.
Hence, the difference between the results of Koyanagi et
al. (6,7) and ours may be accounted for by the absence of
left ventricular hypertrophy and the associated perfusion
abnormalities in our dogs. This would imply that hyper-
trophy is, at least, a necessary cofactor in the exacerbation
of ischemic damage by chronic hypertension.
In a clinical investigation of hypertensive patients with
acute myocardial infarction, Shell and Sobel (3) observed
a reduction in infarct size (estimated from serum creatine
kinase time curves) in the cohort in which blood pressure
was lowered with trimethaphan, suggesting a deleterious
influence of hypertension on ischemic myocardial necrosis.
Our data are not in contrast with these results. The beneficial
effects reported by Shell and Sobel may have resulted, at
least in part, from the diminished myocardial sympathetic
stimulation associated with trimethaphan rather than from
afterload reduction. Furthermore, most patients had chronic
hypertension and, therefore, were likely to have left ven-
tricular hypertrophy. Thus, the difference between our re-
sults and those of Shell and Sobel may be accounted for by
the absence of hypertrophy in our experimental preparation.
A recent preliminary report by Ksiezycka and Maroko
(30) indicates reduction of infarct size in open chest dogs
subjected to acute phenylephrine-induced hypertension.
These results are not in conflict with ours, since several
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differences in model are present. First, in the aforemen-
tioned study (30), arterial pressure was increased by ap-
proximately 90 mm Hg, compared with approximately 40
mm Hg in our investigation. It is conceivable that moderate
and extreme hypertension may have different effects.
Second. in that study, hypertension was associated with a
modest decrease in heart rate, which might have contributed
to reduce infarct size. Third, Ksiezycka and Maroko used
a sustained coronary occlusion resulting in transmural in-
farction, whereas we produced a temporary occlusion re-
sulting in subendocardial infarction. The increase in col-
lateral flow produced by hypertension may be sufficient to
salvage myocardium in the outer but not in the inner half
of the risk region. According to this interpretation, extreme
arterial hypertension may limit the extent of transmural in-
farction, whereas moderate hypertension has no beneficial
effect on subendocardial infarction. The influence of mod-
erate hypertension (which is more common in patients [1,2])
on transmural infarction remains to be determined.
Studies of hypertension and indexes of ischemia.
Previous studies employing indirect assessments of ischemic
damage, such as measurements of ST segment shifts (9,10),
lactate production (11) and intramyocardial carbon dioxide
tension (12), have suggested that acute elevations of arterial
pressure may exert a beneficial effect in dogs without left
ventricular hypertrophy. The apparent discrepancy between
these data and ours may reflect the different severity of the
ischemic insults examined. The aforementioned indexes of
ischemia were evaluated a few minutes after coronary oc-
clusion, before irreversible damage occurs (31), whereas
we assessed the necrosis resulting from 2 hours of ischemia
followed by reperfusion. Thus, although acute hypertension
may alleviate a reversible ischemic insult, it does not appear
to limit myocellular death produced by sustained flow de-
privation. Our findings are consistent with the results of
Roan et al. (12) demonstrating that in dogs without left
ventricular hypertrophy, acute hypertension maintained for
24 hours of coronary occlusion does not significantly affect
contractile function of ischemic myocardium.
Lack of effect of hypertension on infarct size: possible
explanations. The failure of hypertension to affect infarct
size m the present study may be due to the fact that hy-
pertension increases collateral flow to the ischemic region,
but this beneficial effect is offset by a concomitant increase
in oxygen consumption. Alternatively, hypertension may
not Significantly affect either collateral perfusion or oxygen
consumption in the inner half of the risk region, which is
the portion undergoing necrosis in our model. Phenyleph-
ririe-induced hypertension has been suggested to augment
collateral flow to the subepicardium but not to the suben-
docardium (15), presumably because the latter is com-
pressed by the elevated systolic and diastolic left ventricular
pressures. It is also possible that subendocardial oxygen
consumption may not increase despite afterload elevation
because of the severe loss of contractile function that occurs
with acute coronary occlusion (32).
Theoretically, the failure of hypertension to reduce in-
farct size in our study might be attributed to an alpha-
adrenergic-mediated vasoconstriction that limited the in-
crease in collateral perfusion. Such a possibility is unlikely
because alpha-adrenergic stimulation appears to have rela-
tively little influence on native collateral vessels (15,33,34);
however, it cannot be ruled out. From this standpoint, a
model like ours of alpha-agonist-mediated hypertension
might have greater clinical relevance than others, because
hypertension complicating acute myocardial infarction in
human beings appears to result from exaggerated alpha-
adrenergic activity (1,2,13,14).
Clinical implications. Extrapolation of our experi-
mental results to human beings must be done with great
caution, In particular, our data should not be applied to
patients with left ventricular hypertrophy, because this con-
dition may impair the response of ischemic myocardium to
pressure overload with respect to the oxygen supply/demand
ratio. Nevertheless, cardiac hypertrophy is either absent or
minimal in many patients who exhibit elevated arterial pres-
sures during the early phase of myocardial infarction, Our
findings suggest that hypertension is unlikely to have a major
impact on infarct size in this common clinical subset. Ac-
cordingly, antihypertensive therapy aimed solely at limiting
ischemic necrosis may not be warranted.
In summary, previous investigations (6,7) have shown
that chronic arterial hypertension associated with left ven-
tricular hypertrophy increases myocardial infarct size. Our
study demonstrates that hypertension not associated with
hypertrophy does not affect infarct size. Thus, hypertension
may not be deleterious in itself. The exacerbation of isch-
emic damage observed in chronically hypertensive dogs
might depend on the coexistence of left ventricular hyper-
trophy, Further investigation of this hypothesis is warranted.
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